PLIANT THERAPEUTICS, INC.: cash_and_restricted_cash

Value{"amount": 93418000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"}
Period (as of 2025-03-31)
Statuscurrent
EntityPLIANT THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001746473-25-000099 · Open the official SEC filing →
Retrieved: 2026-08-19T17:48:42.383055+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001746473/cash-and-restricted-cash/2025-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/0b3039eb-4cba-49e7-b017-df3ea9717ff0

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies